Editas Medicine, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €5.33M +0.0% -€145.77M +13.7% -2,734.4% -3.3 pp N/A N/A
    (estimated) €5.33M +1.0% -€128.22M +13.3% -2,405.3% -2.6 pp N/A N/A
    (estimated) €5.28M -49.2% -€113.13M +24.2% -2,142.6% -13 pp N/A N/A
    (estimated) €10.40M -40.9% -€91.05M -39.1% -875.7% -0.26 pp -€105.54M -2.0% -1,015.1% -4.0 pp
    (estimated) €17.60M -36.1% -€149.59M -26.0% -849.7% -1.2 pp -€107.69M -37.3% -611.7% +0.12 pp
    €27.56M -58.6% -€202.23M +54.7% -733.7% -5.4 pp -€171.83M +58.1% -623.4% -4.6 pp
    €66.64M +296.3% -€130.69M -25.0% -196.1% +8.4 pp -€108.72M -26.4% -163.2% +7.2 pp
    €16.81M -22.8% -€174.30M +10.4% -1,036.7% -3.1 pp -€147.76M +11.2% -878.8% -2.7 pp
    €21.79M -71.8% -€157.89M +69.2% -724.7% -6.0 pp -€132.91M -9.8% -610.0% -4.2 pp
    €77.39M +341.9% -€93.32M -11.4% -120.6% +4.8 pp -€147.29M +400.5% -190.3% -0.22 pp
    €17.51M -35.7% -€105.31M +12.3% -601.4% -2.6 pp -€29.43M -15.8% -168.0% -0.40 pp
    €27.24M +132.6% -€93.79M -8.6% -344.3% +5.3 pp -€34.93M +456.6% -128.2% -0.75 pp
    €11.71M +126.8% -€102.63M +23.8% -876.5% +7.3 pp -€6.28M -84.2% -53.6% +7.1 pp
    €5.16M +271.6% -€82.89M +33.3% -1,605.5% +29 pp -€39.61M +1,069.0% -767.1% -5.2 pp
    €1.39M +∞% -€62.18M +432.7% -4,475.1% -45 pp -€3.39M -46.6% -243.8% -2.4 pp
    €0.00 +NaN% -€11.67M +155.8% N/A -€6.34M +183.4% N/A
    €0.00 -€4.56M N/A -€2.24M N/A

    Notifications